Navigate this market better. Subscribe for FREE stock alerts and information.

Monday, September 15, 2014

Danaher to purchase Nobel Biocare Holding for $2.2 billion including debt, (NYSE: DHR)

U.S. healthcare conglomerate Danaher Corp said it will purchase Nobel Biocare Holding in an all-cash deal valued at about $2.2 billion, including debt, to widen its market presence in the global dental industry. Danaher said it will offer 17.10 Swiss francs per Nobel Biocare share and the deal is expected to be completed in late 2014 or early 2015.

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. Shares of DHR fell by 0.52% or $-0.4/share to $76.88. In the past year, the shares have traded as low as $66.83 and as high as $81.14. On average, 2825900 shares of DHR exchange hands on a given day and today's volume is recorded at 1914701.